Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus

World J Gastroenterol. 2013 Jan 28;19(4):536-41. doi: 10.3748/wjg.v19.i4.536.

Abstract

Aim: To examine how the expression of caudal type homebox transcription factor 2 (Cdx2) is regulated in the development of malignancy in Barrett's esophagus.

Methods: Cdx2, mucin (MUC) series (MUC2, MUC5AC and MUC6), p53 and E-cadherin expression in Barrett's esophagus and adenocarcinoma specimens were examined by immunostaining. Isolated clusters of cells from (1) MUC2 and Cdx2-positive intestinal metaplastic mucosa; (2) MUC5AC and MUC6-positive, and MUC2 and Cdx2-negative high-grade dysplasia (HD), or intramucosal adenocarcinoma (IMC); and (3) MUC5AC, MUC6 and Cdx2-positive poorly-differentiated invasive adenocarcinoma (PDA) were analyzed by methylation-specific polymerase chain reaction using sets of primers for detecting methylation status of the Cdx2 gene.

Results: Most of the non-neoplastic Barrett's esophageal mucosa showing intestinal-type metaplasia with or without low-grade dysplasia was positive for E-cadherin, MUC series and Cdx2, but negative for p53. A portion of the low-grade to HD was positive for E-cadherin, MUC5AC, MUC6 and p53, but negative for MUC2 and Cdx2. The definite IMC area was strongly positive for MUC5AC, MUC6 and p53, but negative for MUC2 and Cdx2. Methylation of the Cdx2 promoter was not observed in intestinal metaplasia, while hypermethylation of part of its promoter was observed in hot dipped and IMC. Hypermethylation of a large fraction of the Cdx2 promoter was observed in PDA.

Conclusion: Cdx2 expression is restored irrespective of the methylation status of its promoter. Apparent positive immunohistochemical results can be a molecular mark for gene silencing memory.

Keywords: Barrett¡’s esophagus; Caudal type homebox transcription factor 2; Intestinal metaplasia; Promoter hypermethylation.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / chemistry*
  • Adenocarcinoma / genetics
  • Adenocarcinoma / pathology
  • Aged, 80 and over
  • Barrett Esophagus / genetics
  • Barrett Esophagus / metabolism*
  • Barrett Esophagus / pathology
  • Biomarkers, Tumor / analysis*
  • Biomarkers, Tumor / genetics
  • Biopsy
  • CDX2 Transcription Factor
  • DNA Methylation*
  • Disease Progression
  • Esophageal Neoplasms / chemistry*
  • Esophageal Neoplasms / genetics
  • Esophageal Neoplasms / pathology
  • Esophagus / chemistry*
  • Esophagus / pathology
  • Homeodomain Proteins / analysis*
  • Homeodomain Proteins / genetics
  • Humans
  • Immunohistochemistry
  • Male
  • Metaplasia
  • Polymerase Chain Reaction
  • Precancerous Conditions / chemistry*
  • Precancerous Conditions / genetics
  • Precancerous Conditions / pathology
  • Predictive Value of Tests
  • Promoter Regions, Genetic*

Substances

  • Biomarkers, Tumor
  • CDX2 Transcription Factor
  • CDX2 protein, human
  • Homeodomain Proteins

Supplementary concepts

  • Adenocarcinoma Of Esophagus